data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Cidara Therapeutics
(NASDAQ:CDTX)
$0.449
00
At close: Jul 1
$0.449
00
After Hours: 4:00PM EDT
Day High/Low- - -
52 Week High/Low0.4 - 2.39
Open / Close- / -
Float / Outstanding68M / 69M
Vol / Avg.- / 298.2K
Mkt Cap31M
P/E-
50d Avg. Price0.55
Div / Yield-
Payout Ratio-
EPS-0.27
Total Float68M

Cidara Therapeutics (NASDAQ:CDTX), Quotes and News Summary

Cidara Therapeutics (NASDAQ: CDTX)

Day High/Low- - -
52 Week High/Low0.4 - 2.39
Open / Close- / -
Float / Outstanding68M / 69M
Vol / Avg.- / 298.2K
Mkt Cap31M
P/E-
50d Avg. Price0.55
Div / Yield-
Payout Ratio-
EPS-0.27
Total Float68M
Benzinga - Jun 9, 2022, 5:44AM
Benzinga - May 12, 2022, 3:36PM
Benzinga - May 12, 2022, 7:51AM
Benzinga - May 11, 2022, 4:21PM
Benzinga - Apr 25, 2022, 7:40AM
Benzinga - Apr 25, 2022, 7:11AM
Benzinga - Apr 14, 2022, 8:08AM
Benzinga - Mar 31, 2022, 8:03AM
Benzinga - Mar 7, 2022, 5:21PM
Benzinga - Mar 3, 2022, 7:18AM
Benzinga - Feb 14, 2022, 10:12AM
Benzinga - Feb 14, 2022, 8:01AM
Benzinga - Dec 14, 2021, 2:28PM
Benzinga - Dec 14, 2021, 11:34AM
Benzinga - Dec 14, 2021, 7:02AM
Benzinga - Dec 14, 2021, 6:57AM
load more
Sector: Health Care.Industry: Biotechnology
Cidara Therapeutics Inc is a biotechnology company. It is focused on the discovery, development, and commercialization of novel anti-infectives for the treatment and prevention of diseases. The company's Rezafungin is a novel molecule in the echinocandin class of antifungals. It is developing rezafungin for the first-line treatment and prevention of serious, invasive fungal infections which are associated with high mortality rates. Its other product candidates include CD377, CD388, RSV AVC, HIV AVC, and SARS-CoV-2 AVC.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-11
REV
Q1 2022Est.ActualSurprise
EPS-0.290-0.270 0.0200
REV6.110M7.109M999.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Cidara Therapeutics Questions & Answers

Q
How do I buy Cidara Therapeutics (CDTX) stock?
A

You can purchase shares of Cidara Therapeutics (NASDAQ: CDTX) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Cidara Therapeutics's (CDTX) competitors?
Q
What is the target price for Cidara Therapeutics (CDTX) stock?
A

The latest price target for Cidara Therapeutics (NASDAQ: CDTX) was reported by HC Wainwright & Co. on Thursday, May 12, 2022. The analyst firm set a price target for 6.00 expecting CDTX to rise to within 12 months (a possible 1236.30% upside). 3 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Cidara Therapeutics (CDTX)?
A

The stock price for Cidara Therapeutics (NASDAQ: CDTX) is $0.449 last updated July 1, 2022, 8:00 PM UTC.

Q
Does Cidara Therapeutics (CDTX) pay a dividend?
A

There are no upcoming dividends for Cidara Therapeutics.

Q
When is Cidara Therapeutics (NASDAQ:CDTX) reporting earnings?
A

Cidara Therapeutics’s Q2 earnings are confirmed for Thursday, August 11, 2022.

Q
Is Cidara Therapeutics (CDTX) going to split?
A

There is no upcoming split for Cidara Therapeutics.

Q
What sector and industry does Cidara Therapeutics (CDTX) operate in?
A

Cidara Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.